arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 9/2020 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    SARS-CoV-2: vaccines, convalescent plasma and other treatments … FDA bows to political pressure

    New German „real world“ data: higher stroke frequency with new oral anticoagulants

    NEW ON THE MARKET

    Tafamidis (VYNDAQEL 61 mg) for cardiac transthyretin amyloidosis (short version)

    THERAPY FROM A CRITICAL VIEWPOINT

    Empagliflozin (JARDIANCE): second study with an SGLT2 inhibitor in heart failure

    Rhythm or frequency control for atrial fibrillation: What is new?

    BEWARE MISINFORMATION

    Inactivated bifidobacteria (KIJIMEA REIZDARM PRO) for irritable bowel syndrome

    IN BRIEF

    Antithrombotic therapy after transcatheter aortic-valve implantation (TAVI)

    Dexamethasone (FORTECORTIN, generics): European Medicines Agency supports use in COVID-19

    SARS-CoV-2 vaccine: lack of transparency after trial interruption

    Echinacea against SARS-CoV-2?
    free

    Ulipristal (ESMYA) for uterine myoma: withdrawal of marketing authorisation recommended

    SIDE EFFECTS

    Acute generalized exanthematous pustulosis with (val)aciclovir

    e a-t ON THE INTERNET

    Tafamidis (VYNDAQEL 61 mg) for cardiac transthyretin amyloidosis (long version)

    Once again: on the substitution of original preparations with an application patent

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!